XL t(6;11) AFDN/KMT2A DF

Translocation/Dual Fusion Probe

Order Number
D-5132-100-OG
Package Size
100 µl (10 Tests)
Labels
  
Chromosomes
611
Regulatory Status
IVDD

IVDR Certification

This probe is IVDR-certified in compliance with the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).

MetaSystems Probes has already certified a wide range of FISH probes, according to IVDR.

This product remains IVDD-certified until further notice.

Please use the switch to change to the IVDR product.

IVDDIVDRDiscover all IVDR-certified products

Product Description

XL t(6;11) AFDN/KMT2A DF

XL t(6;11) AFDN/KMT2A DF consists of an orange-labeled probe hybridizing to the AFDN gene region at 6q27 and a green-labeled probe hybridizing to the KMT2A gene region at 11q23.3.

Probe maps for selected products have been updated. These updates ensure a consistent presentation of all gaps larger than 10 kb including adjustments to markers, genes, and related elements. This update does not affect the device characteristics or product composition. Please refer to the list to find out which products now include updated probe maps.

Probe map details are based on UCSC Genome Browser GRCh37/hg19, with map components not to scale.

Need assistance or a quote?

Clinical Details

Clinical Applications

  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myelogenous Leukemia (AML)
Need assistance or a quote?

Images

XL t(6;11) AFDN/KMT2A DF

XL t(6;11) AFDN/KMT2A DF hybridized to bone marrow cells, two aberrant cells are shown. Translocations are typically observed as one orange and one green signal clearly separated and two orange-green colocalization/fusion signals.

Need assistance or a quote?

Expected Patterns

Expected Pattern 1

Normal Cell:
Two green (2G) and two orange (2O) signals.

Expected Pattern 2

Aberrant Cell (typical results):
One green (1G), one orange (1O), and two green-orange colocalization/fusion signals (2GO) resulting from a reciprocal translocation between the respective loci.

Need assistance or a quote?

Literature

  • De Braekeleer et al (2011) Mol Oncol 5:555-563
  • Meyer et al (2013) Leukemia 27:2165-2176
  • Meyer et al (2017) Leukemia 32:273–284

Downloads

News